Orlistat
Anti-Obesity Drugs
PRESENTATION:
Nofat 120 Capsule: Each capsule contains Orlistat pellets equivalent to 120 mg Orlistat USP.
INDICATION:
Adults: Orlistat is indicated in conjunction with a mildly hypocaloric diet for the treatment of obese patients with a body mass index (BMI)>30 kg/m2 and overweight patients (BMI >28 kg/m2 ) with associated risk factors such as type II diabetes, hyperlipidemia and hypertension. Treatment with Orlistat should be discontinued after 12 weeks in patients who have not lost at least 5% of their body weight as measured at the start of drug therapy.
Adolescents (12 years & older): Obese adolescents should be treated with Orlistat only if an adequate reduction of body weight cannot be achieved by means of diet & increased physical activity. Treatment with orlistat should be considered in particular if complications of obesity are present.
PACKAGING:
Nofat 120 Capsule: Each box contains 2X10 capsules in blister pack.